Turk J Ophthalmol. 2021 Feb 25;51(1):45-54. doi: 10.4274/tjo.galenos.2020.11456.
PMID:33631915
Blepharoconjunctivitis.
Zeppieri M, Patel BC.
2025 Dec 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
PMID:32644328
Blepharoconjunctivitis.
McCulley JP.
Int Ophthalmol Clin. 1984 Summer;24(2):65-77. doi: 10.1097/00004397-198424020-00009.
PMID:6233233
Dupilumab-associated blepharoconjunctivitis.
Paulose SA, Sherman SW, Dagi Glass LR, Suh LH.
Am J Ophthalmol Case Rep. 2019 Sep 5;16:100550. doi: 10.1016/j.ajoc.2019.100550. eCollection 2019 Dec.
PMID:31535057
[Dupilumab-related blepharoconjunctivitis: Recommendations of the CEDRE group. Atopic dermatitis, conjunctivitis and dupilumab: Which management approach?].
Doan S, Arnould L, Febvay C, Fournié P, Gueudry J, Labalette P, Ouilhon C, Tran TH, Vabres B, Barbarot S, Bouaziz JD, Du-Thanh A, Jachiet M, Seneschal J, Soria A, Staumont-Sallé D, Baudouin C, Mortemousque B.